• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

文莱肺癌患者中表皮生长因子受体(EGFR)蛋白的过表达

Overexpression of EGFR protein in Bruneian lung cancer patients.

作者信息

Han Yu Hao, Abdul Hamid Mas R W, Telisinghe Pemasiri Upali, Haji Hussin Juniadah Binti, Mabruk Mohamed

机构信息

PAPRSP Institute of Health Sciences, University of Brunei Darussalam, Gadong, Brunei Darussalam E-mail : mohamed.mabruk@.ubd.edu.bn ;

出版信息

Asian Pac J Cancer Prev. 2015;16(1):233-7. doi: 10.7314/apjcp.2015.16.1.233.

DOI:10.7314/apjcp.2015.16.1.233
PMID:25640358
Abstract

BACKGROUND

Lung cancer is the leading cause of cancer death in Brunei Darussalam, accounting for almost 20% of the total. The epidermal growth factor receptor (EGFR) is a member of the erbB family of tyrosine kinase receptor proteins, which includes c-erbb2(HER2/neu), erb-B3, and erb-B4. EGFR overexpression is found in a third of all epithelial cancers, often associated with a poor prognosis.

MATERIALS AND METHODS

Protein expression of EGFR in 27 cases of lung cancer tissue samples and 9 cases of normal lung tissue samples was evaluated using an immunohistochemical approach.

RESULTS

The results demonstrated significant increase and overexpression of EGFR in Bruneian lung cancer tissue samples in comparison to normal lung tissue. However, there was no significant relationship between clinicopathologic variables (age and sex) of patients and EGFR protein expression.

CONCLUSIONS

EGFR is overexpressed in Bruneian lung cancer patient tissue samples in comparison to normal lung tissue samples. This may indicate that EGFR protein over expression plays an important role in the genesis of this type of cancer in Brunei Darussalam.

摘要

背景

肺癌是文莱达鲁萨兰国癌症死亡的主要原因,占总数的近20%。表皮生长因子受体(EGFR)是酪氨酸激酶受体蛋白erbB家族的成员,该家族包括c-erbb2(HER2/neu)、erb-B3和erb-B4。在三分之一的上皮癌中发现EGFR过表达,通常与预后不良相关。

材料与方法

采用免疫组织化学方法评估27例肺癌组织样本和9例正常肺组织样本中EGFR的蛋白表达。

结果

结果显示,与正常肺组织相比,文莱肺癌组织样本中EGFR显著增加且过表达。然而,患者的临床病理变量(年龄和性别)与EGFR蛋白表达之间无显著关系。

结论

与正常肺组织样本相比,文莱肺癌患者组织样本中EGFR过表达。这可能表明EGFR蛋白过表达在文莱达鲁萨兰国这类癌症的发生中起重要作用。

相似文献

1
Overexpression of EGFR protein in Bruneian lung cancer patients.文莱肺癌患者中表皮生长因子受体(EGFR)蛋白的过表达
Asian Pac J Cancer Prev. 2015;16(1):233-7. doi: 10.7314/apjcp.2015.16.1.233.
2
Epidermal growth factor receptor expression status in lung cancer correlates with its mutation.肺癌中表皮生长因子受体的表达状态与其突变相关。
Hum Pathol. 2005 Oct;36(10):1127-34. doi: 10.1016/j.humpath.2005.08.007.
3
Prevalence, clinicopathologic characteristics, and molecular associations of EGFR exon 20 insertion mutations in East Asian patients with lung adenocarcinoma.东亚肺腺癌患者中表皮生长因子受体(EGFR)第20外显子插入突变的患病率、临床病理特征及分子关联
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S490-6. doi: 10.1245/s10434-013-3452-1. Epub 2014 Jan 14.
4
EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.中国肺癌患者中 EGFR 和 ERBB2 种系突变及其在癌症遗传易感性中的作用。
J Thorac Oncol. 2019 Apr;14(4):732-736. doi: 10.1016/j.jtho.2018.12.006. Epub 2019 Jan 2.
5
Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients.表皮生长因子受体(EGFR)酪氨酸激酶抑制剂治疗EGFR突变阳性非小细胞肺癌的特征及总生存期:对1660例日本患者的回顾性分析
Jpn J Clin Oncol. 2016 May;46(5):462-7. doi: 10.1093/jjco/hyw014. Epub 2016 Mar 13.
6
Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.非小细胞肺癌中表皮生长因子受体基因突变的临床病理特征
J Thorac Oncol. 2006 Mar;1(3):231-9. doi: 10.1016/s1556-0864(15)31573-2.
7
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.表皮生长因子受体和HER2-neu蛋白的同步过表达是I期非小细胞肺癌患者预后不良的一个预测指标。
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):136-43. doi: 10.1158/1078-0432.ccr-0373-3.
8
MET expression plays differing roles in non-small-cell lung cancer patients with or without EGFR mutation.MET 表达在有或没有 EGFR 突变的非小细胞肺癌患者中发挥不同的作用。
J Thorac Oncol. 2014 May;9(5):725-8. doi: 10.1097/JTO.0000000000000105.
9
[Correlation Study on Expression of PD-1 and PD-L1 in Non-small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations].非小细胞肺癌中PD-1与PD-L1表达及表皮生长因子受体突变的相关性研究
Zhongguo Fei Ai Za Zhi. 2021 Sep 20;24(9):623-631. doi: 10.3779/j.issn.1009-3419.2021.102.31. Epub 2021 Aug 30.
10
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.抑制表皮生长因子受体可抑制肿瘤中甲状旁腺激素相关蛋白的表达,并改善癌症相关性恶病质。
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1582-1594. doi: 10.1002/jcsm.12985. Epub 2022 Apr 4.

引用本文的文献

1
Measurement of Serum EGFR mRNA Expression is a Reliable Predictor of Treatment Response and Survival Outcomes in Non- Small Cell Lung Cancer.血清 EGFR mRNA 表达的测量是预测非小细胞肺癌治疗反应和生存结局的可靠指标。
Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3153-3163. doi: 10.31557/APJCP.2020.21.11.3153.
2
Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.环磷酸鸟苷依赖蛋白激酶 II 抑制表皮生长因子 (EGF)/表皮生长因子受体 (EGFR) 诱导的骨肉瘤细胞的生物学效应。
Med Sci Monit. 2018 Apr 4;24:1997-2002. doi: 10.12659/msm.905892.
3
Advances in studies of tyrosine kinase inhibitors and their acquired resistance.
酪氨酸激酶抑制剂及其获得性耐药的研究进展。
Mol Cancer. 2018 Feb 19;17(1):36. doi: 10.1186/s12943-018-0801-5.
4
Association between EGFR polymorphisms and the risk of lung cancer.表皮生长因子受体基因多态性与肺癌风险之间的关联。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15245-9. eCollection 2015.